Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative.
Autori:
Giorgi Rossi P, Lebeau A, Canelo-Aybar C, Saz-Parkinson Z, Quinn C, Langendam M, Mcgarrigle H, Warman S, Rigau D, Alonso-Coello P, Broeders M, Graewingholt A, Posso M, Duffy S, Schünemann HJ; ECIBC Contributor Group.
Rivista:
Br J Cancer 2021; 124: 1503-1512. doi: 10.1038/s41416-020-01247-z. Epub 2021 Feb 18. PMID: 33597715 (IF 7.640)